Sublingual apomorphine in the treatment of Parkinson’s disease
Journal of Neural Transmission · 2024
DOI: 10.1007/s00702-024-02777-z ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neural Transmission, 2024. Verfasst von Jan Kassubek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Parkinson Disease, Apomorphine, Antiparkinson Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Advanced Parkinson´s disease (PD) is often complicated by fluctuations of disability depending on plasma levels of levodopa. For most patients OFF phases with worsening of tremor and immobility, but also pain, depression, autonomic symptoms are troublesome. While adjustments of levodopa administrations can relief such fluctuations for some time, "on demand" therapies become more and more important. These "on demand" therapies should provide fast and efficacious relief. During the past years, new options for on demand therapies in PD-associated OFF episodes have been developed, including new formulations of levodopa and apomorphine to provide fast and readily accessible on demand treatment. In this narrative review, the challenges of the treatment of PD-associated fluctuations and OFF states are addressed, with a special focus on sublingual apomorphine (SL-APO) including the results from recent clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University Hospital Ulm, Ulm, Germany.
- German Centre for Neurodegenerative Diseases (DZNE), Ulm, Germany.
- Parkinson-Klinik Ortenau, Kreuzbergstr. 16, 77723, Wolfach, Germany. w.jost@parkinson-klinik.de.
- Kreisklinik Ebersberg, Ebersberg, Germany.
ORCID-Profile: Wolfgang H Jost
Zitieren
APA
Kassubek, J., Jost, W. H., & Schwarz, J. (2024). Sublingual apomorphine in the treatment of Parkinson’s disease. Journal of Neural Transmission. https://doi.org/10.1007/s00702-024-02777-z
Vancouver
Kassubek J, Jost WH, Schwarz J. Sublingual apomorphine in the treatment of Parkinson’s disease. Journal of Neural Transmission. 2024. doi:10.1007/s00702-024-02777-z
BibTeX
@article{Kassubek2024,
author = {Kassubek, Jan and Jost, Wolfgang H and Schwarz, Johannes},
title = {Sublingual apomorphine in the treatment of Parkinson’s disease},
journal = {Journal of Neural Transmission},
year = {2024},
doi = {10.1007/s00702-024-02777-z}
}
EUVIMED